Delin Ventures: Investment Portfolio & Startup News

Delin Ventures

To add a bio or update investment portfolio click update information.

Investment Portfolio

Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions

Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions

Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions

Athernal Bio is developing immunotherapies for clonal haematopoiesis, aiming to stop blood cancers before they develop in high-risk patients.

Delin Ventures

More venture news

Ancep
10 Nov 2026
Ancep raises £6m in funding led by Creandum to help insurance brokers cover the clients they’d normally turn down
EquityEnterprise
Crowd Threat
9 Nov 2026
Crowd Threat lands £1m in funding from Mercia Ventures and PXN Group to track global security risks through local reports
EquityDefence
Luthmore
27 Oct 2026
Luthmore secures £5m from the FSE Group to roll out its battery-powered zero-emissions boiler
EquityIndustrial